Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP
Author:
Hsiao Victoria C.1, Tian Rujin1, Long Heather2, Der Perng Ming2, Brenner Michael3, Quinlan Roy A.2, Goldman James E.1
Affiliation:
1. Department of Pathology and the Center for Neurobiology and Behavior, Columbia University, New York, NY 10032, USA 2. School of Biological and Medical Sciences, University of Durham, Durham, DH1 3LE, UK 3. Department of Neurobiology, and The Civitan International Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
Abstract
Alexander disease is a fatal neurological illness characterized by white-matter degeneration and the formation of astrocytic cytoplasmic inclusions called Rosenthal fibers, which contain the intermediate filament glial fibrillary acidic protein (GFAP), the small heat-shock proteins HSP27 and αB-crystallin, and ubiquitin. Many Alexander-disease patients are heterozygous for one of a set of point mutations in the GFAP gene, all of which result in amino acid substitutions. The biological effects of the most common alteration, R239C, were tested by expressing the mutated protein in cultured cells by transient transfection. In primary rat astrocytes and Cos-7 cells, the mutant GFAP was incorporated into filament networks along with the endogenous GFAP and vimentin, respectively. In SW13Vim– cells, which have no endogenous cytoplasmic intermediate filaments, wild-type human GFAP frequently formed filamentous bundles, whereas the R239C GFAP formed `diffuse' and irregular patterns. Filamentous bundles of R239C GFAP were sometimes formed in SW13Vim– cells when wild-type GFAP was co-transfected. Although the presence of a suitable coassembly partner (vimentin or GFAP) reduced the potential negative effects of the R239C mutation on GFAP network formation, the mutation affected the stability of GFAP in cells in a dominant fashion. Extraction of transfected SW13Vim– cells with Triton-X-100-containing buffers showed that the mutant GFAP was more resistant to solubilization at elevated KCl concentrations. Both wild-type and R239C GFAP assembled into 10 nm filaments with similar morphology in vitro. Thus, although the R239C mutation does not appear to affect filament formation per se, the mutation alters the normal solubility and organization of GFAP networks.
Publisher
The Company of Biologists
Reference66 articles.
1. Alexander, W. S. (1949). Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain72, 373-381. 2. Aoki, Y., Haginoya, K., Munakata, M., Yokoyama, H., Nishio, T., Togashi,
N., Ito, T., Suzuki, Y., Kure, S., Iinuma, K. et al. (2001). A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease. Neurosci. Lett.312, 71-74. 3. Bettica, A. and Johnson, A. B. (1990). Ultrastructural immunogold labeling of glial filaments in osmicated and unosmicated epoxy-embedded tissue. J. Histochem. Cytochem.38, 103-109. 4. Borrett, D. and Becker, L. E. (1985). Alexander's disease: a disease of astrocytes. Brain109, 367-385. 5. Brenner, M., Lampel, K., Nakatani, Y., Mill, J., Banner, C., Mearow, K.,
Dohadwala, M., Lipsky, R. and Freese, E. (1990). Characterization of human cDNA and genomic clones for glial fibrillary acidic protein. Mol. Brain Res.7, 277-286.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|